Content begins here

RePORT International Resources

View all training resources.

335 items found
Funding

NIH - Research on Chatbots and their Usage [This is not a notice of funding opportunity (NOFO)]

Background: Conversational chatbots are increasingly integrated into daily life, including in health-related information-seeking, decision support, social interaction, and informal caregiving contexts. These systems are now used by individuals to interpret symptoms, manage chronic conditions, make financial and health decisions, and mitigate social isolation, often without professional oversight. Use of chatbot technologies is expanding rapidly, and patterns of adoption, benefit, and risk are likely to differ across populations, contexts, and system designs. At present, there is insufficient evidence regarding the benefits and harms of chatbot use for health and well-being or to characterize unintended consequences such as misinformation, over-reliance, altered decision-making, or delayed engagement with professional care. Rigorous research is needed to understand how chatbot design (including potential built-in safeguards), chatbot use (including but not limited to context and frequency of use), and user characteristics interact to shape health-relevant outcomes. Efforts should inform safeguards, standards, and evidence-based guidance. Purpose: This topic encourages multidisciplinary research that identifies, measures, and explains the benefits and harms associated with chatbot use (both chatbot-based interventions or treatments and routine chatbot use) across a variety of populations, use cases, and settings. Of interest are studies that move beyond proof-of-concept to characterize mechanisms, safety, and impacts on behavior, decision-making, and health outcomes. Of particular interest are studies that: - Identify risk mechanisms: including automation bias, persuasive effects, misinformation exposure, behavioral dependency, and substitution for professional care, and document adverse outcomes across different chatbot designs, and health or wellbeing-related purposes. - Compare safety and performance across chatbot models, including adaptive versus static designs and varying degrees of personalization, information retrieval, or relational engagement. - Examine impacts on decision-making and autonomy: including how chatbot use influences judgment, independence, help-seeking behavior, and relationships with family, caregivers, and clinicians. - Characterize health and functional outcomes associated with patterns of use: including frequency, duration, and longitudinal engagement, with attention to cognitive, emotional, social, and behavioral consequences. - Develop and test safeguards: including monitoring strategies and design features that promote safe, ethical, secure, and beneficial use, particularly for populations at elevated risk of harm. - Ideally, studies will focus on advancing understanding of causal mechanisms driving observed or hypothesized effects and emphasize methodological rigor, appropriate comparators, and real-world relevance.
Research Tools

NIH Extramural Nexus (News)

The NIH Extramural Nexus is the NIH's official platform for updates on grants policies, application processes, and funding news. Hosted within the NIH Grants & Funding website, it serves as a centralized resource for researchers, administrators, and institutions navigating the NIH extramural research landscape. The platform offers timely information on policy changes, application tips, and new resources, ensuring the research community stays informed and compliant with NIH requirements.
Research Tools

NIH Grants Process for Beginners: Webinar Resources Available

Learn the basics with NIH Grants Process: A Walk-Through for Beginners Tune in for answers to your questions in the NIH Expert Q&A Panel: Part 1 Test your knowledge with Submission Policies: You Make the Call More questions and answers in the NIH Expert Q&A Panel: Part 2 Take our panelists’ advice: Grant Application Tips from NIH Experts
Webinar
Funding

NIH Research Project Grant (Parent R01 Clinical Trial Required)

The NIH Research Project Grant supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). This Parent Notice of Funding Opportunity Announcement requires that at lease 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.
Funding

NIH Support of International Research: Navigating NIH Public Resources

Fogarty's new webpage 'NIH Support of International Research: Navigating NIH Public Resources' website page contains useful information for researchers. Alongside links to NIH Guide Notices and NIH extramural news resources, the page offers guidance on the newly published application and award structure for applications that request funding for international organizations (the PA-26-002 NIH Collaborative International Research Project--Parent PF5 Clinical Trial Optional).
Funding

NIH: Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)

Funding Opportunity Purpose: The purpose of this notice of funding opportunity (NOFO) is to support innovative basic, clinical, translational, and implementation science research relevant to HIV and substance use. This initiative encourages high risk high impact transformative studies that advance knowledge and strategies for HIV prevention, diagnosis, treatment and virus suppression in people who use substances and/or have a substance use disorder. Funding Opportunity Goal(s): To support basic, clinical, translational, and implementation research in the field of substance use. To develop new knowledge and approaches for the prevention, diagnosis, and treatment of drug use, misuse, and addiction, drug overdose, and related health outcome, including HIV/AIDS. Application due date: Multiple dates, see announcement.
Research Tools

NIH: DAIDS Learning Portal

Most important training for any investigator would be HSP/GCP where they need to learn and understand how Ethical conduct of research is done and why it is important. I have pasted various links below that cover all the topics extensively. DAIDS learning portal, HANC network , DAIDS score manual have good training modules .
Research Tools

NIH: DAIDS SCORE Manual

This document provides a detailed list of source documentation requirements during the conduct of a clinical trial. Source documentation refers to the record of the participant before, during and after a trial.
Funding

NIH: Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Application due date: Multiple dates, see announcement
Grant
Funding

NIH: Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

Application due date: Multiple dates, see announcement
Grant
Funding

NIH: Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (herein referred to collectively as evidence-based interventions). Studies that promote the dissemination and implementation of evidence-based interventions among relevant communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services that may be disrupted amidst disasters remain relevant. All applications must be within the scope of the mission of one of the Institutes/Centers listed in the notice. Application DEADLINE: Multiple dates, see announcement.
Funding

NIH: Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

Application due date: Multiple dates, see announcement
Grant
Funding

NIH: HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)

Funding Opportunity Purpose: The goal of this notice of funding opportunity (NOFO) is to address the opioid crisis and/or overdose events by supporting action-oriented research, accelerating the translation of addiction epidemiology, prevention, treatment services, and recovery research to practice. Proposed studies may target the individual, provider, organizational, community, or system level. This initiative prioritizes replicable and scalable approaches for accelerating the routine use of effective, evidence-based prevention, treatment and recovery interventions and services. The translation of research to practice and research relevant to chronic pain comorbid with substance use is also a priority. Research may deploy a variety of methods and approaches, including but not limited to identifying and characterizing malleable factors, developing and testing interventions and implementation strategies, deploying and testing collaborative data science approaches, and/or developing and testing approaches that integrate the collaboration of researchers and decision-makers at any levels (e.g., clinical-, health system-, public health- or policy-level). Funding Opportunity Goal(s): To support basic, clinical, translational, and implementation research in the field of substance use. To develop new knowledge and approaches for the prevention, diagnosis, and treatment of drug use, misuse, and addiction, drug overdose, and related health outcome, including HIV/AIDS. Application due date: Multiple dates, see announcement.
Research Tools

NIH: Peer Review Webinars & Videos

The NIH Center for Scientific Review has produced a series of webinars and videos to give you an inside look at how scientists from across the country review NIH grant applications for scientific and technical merit.
Webinar
Training & Conferences

NIH: Pragmatic and Group-Randomized Trials in Public Health and Medicine

This online course is presented by Dr. David M. Murray, the NIH Associate Director for Prevention and Director of Office of Disease Prevention. This course, updated in September 2024, is meant to help researchers design trials involving groups or clusters.
Online
Funding

NIH: Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)

Funding Opportunity Purpose: The purpose of this notice of funding opportunity (NOFO) is to facilitate the entry of investigators into multiple high-priority areas of substance use research, including comorbidity with HIV. The Science Track Award for Research Transition (START) Program aims to provide investigators with the opportunity to gather preliminary data that will assist them in securing future research grants and advancing their scientific careers. Funding Opportunity Goal(s): To support basic, clinical, translational, epidemiological, or intervention science in the field of substance use. To develop new skillsets, knowledge, and/or approaches for the prevention, diagnosis, and treatment of substance use, misuse, addiction, drug overdose, and related health outcomes, including HIV/AIDS. Application due date: Multiple dates, see announcement.
Research Tools

NLM Style Guide for Authors, Editors, and Publishers

Citing Medicine provides assistance to authors in compiling lists of references for their publications, to editors in revising such lists, to publishers in setting reference standards for their authors and editors, and to librarians and others in formatting bibliographic citations.
Funding

NOFO: Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R01 Clinical Trial Not Allowed)

Open Date (Earliest Submission Date): April 07, 2025; Expiration Date: January 08, 2028 Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project. Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is five years.
Funding

NOFO: Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)

Open Date (Earliest Submission Date): May 07, 2025; Expiration Date: January 08, 2028 Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project. Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is five years.
Funding

NOFO: Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)

Open Date (Earliest Submission Date): May 07, 2025; Expiration Date: January 08, 2028 Award Budget: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 in direct costs may be requested in any single year. Award Project Period may not exceed 2 years.
1 2 7 8 9 16 17